About PRA International

The future of clinical trial site and patient recruitment is here
22-Jul-2010 at 11:30 AM EDT. Presented by Kent Thoelke, Senior VP Scientific and Medical Affairs, PRA International. Click here for more information.

In the article Biomarkers: Promises and Challenges Jerome Wilson and Martin Nemansky, explore some of the difficulties of implementing biomarkers during drug development. Click here to read the full article.

PRA International appoints Colin Shannon as CEO, effective 01-Jan-2010. To read the press release, click here.

Investigator Relationships Support On-Time Recruitment
"The PRA clinical operations team is exceptional... far better than we have ever worked with from other CROs!"—Client's Leader Biometrics and Data Management

PRA Concentrates on Central Europe for NSCLC Trial
"I have never seen a lung cancer study recruit so quickly!"—Client's Head, Global Clinical Development

PRA International Formalizes Partnership with Oncopartners and IBPC, accelerating the Clinical Development of New Cancer Treatments in Brazil
To read more, click here

PRA conducts a comprehensive range of clinical trial services in Latin America, including a drug safety center in São Paulo, Brazil.